CRC Credit Research Compendium
Menu

Issuer Credit Research

Issuer Flash: UPL Limited / UPL Corporation

Issuer: Upl | Document: Issuer Flash | Date: 2026-08-04 | Event: Q1fy2027 Results

Report date: 2026-08-04 Event date: 2026-08-03 Event title: Q1 FY2027 Results

1. Flash Conclusion

UPL's Q1 FY2027 results provide further evidence that the operating recovery described in the May 2026 issuer summary has continued. Consolidated revenue rose 10% year on year to INR101.81bn and EBITDA rose 15% to INR15.00bn, with the EBITDA margin expanding to 14.7%. The international crop-protection platform, UPL Corporation Ltd. (UPL Corp), also improved: revenue grew 7% and EBITDA 38%, lifting its EBITDA margin to 8.4%. These outcomes are supportive for group credit quality because they show margin progress despite weather-related volume pressure in Europe and wider macro uncertainty.

The credit read-through remains qualified rather than unequivocally positive. Net debt was broadly unchanged from June 2025 at USD2.50bn, while Q1 working capital increased materially and reported operating cash flow and free cash flow to firm were negative. Management attributes the increase mainly to seasonal inventory and receivables movements, but the result reinforces that cash conversion and short-term funding usage remain more important for creditors than the headline EBITDA trajectory alone. The Q1 event therefore supports the existing view of an improving but cyclical credit; it does not resolve the still-unconfirmed UPL Corp bondholder perimeter, refinancing, covenant and liquidity questions.

2. Q1 Results: Margin Expansion Continued, but Q1 Cash Was Absorbed

The unaudited consolidated results were approved on 3 August 2026 and received an unmodified limited-review conclusion from B S R & Co. LLP. This is a review conclusion rather than an audit opinion. Revenue, contribution and EBITDA all grew, supported by pricing, mix, capacity utilisation and favourable foreign exchange. Consolidated PBT nevertheless remained negative at INR1.09bn. PATMI turned marginally positive at INR0.10bn, compared with a loss of INR0.88bn in Q1 FY2026, aided by higher EBITDA, lower net finance cost and a lower net exchange impact.

Metric Q1 FY2027 Q1 FY2026 Credit reading
Consolidated revenue INR101.81bn INR92.16bn 10% growth, with positive pricing and FX support; it is not solely a volume-led recovery.
Consolidated EBITDA / margin INR15.00bn / 14.7% INR13.03bn / 14.1% 15% EBITDA growth and 60bp margin expansion extend the recovery.
UPL Corp revenue / EBITDA margin INR63.74bn / 8.4% INR59.57bn / 6.5% Profitability improved at the key overseas crop-protection platform, although its creditor linkage to group cash flow remains unverified.
Net debt / net debt-to-EBITDA USD2.50bn / 2.4x USD2.49bn / 2.6x Year-on-year gearing improved, but net debt was essentially flat.
Net working capital days 110 days 86 days A 24-day increase increased seasonal funding needs and bears monitoring.
Reported operating cash flow / FCFF -INR62.04bn / -INR77.78bn -INR26.87bn / -INR31.41bn Negative Q1 cash flow widened as working capital, capex and investments consumed cash.

Note: income-statement and cash-flow measures are for the quarter ended 30 June 2026; debt, gearing, working-capital days and factoring are point-in-time measures as of that date. UPL Corp platform, debt, working-capital, factoring and cash-flow figures are company-disclosed metrics from UPL's Q1 FY2027 investor presentation, not audited UPL Corp standalone issuer financials.

At platform level, UPL Corp's contribution margin rose 340bp to 38.2%. The presentation attributes the revenue increase partly to a 14% foreign-exchange benefit, while volume declined 7% because of unfavourable European weather and pressure in Latin America. The improvement in EBITDA is therefore helpful but does not yet demonstrate a broad-based volume recovery. Advanta and SUPERFORM added diversification: their revenue increased 26% and 14%, respectively. Those management platforms should not be added to audited segments or assumed to be freely available to UPL Corp noteholders.

3. Credit Read-Through: Better Earnings Do Not Yet Prove Better Cash Conversion

The balance sheet remains the principal counterweight to the improved profitability. Gross debt fell to USD3.02bn from USD3.13bn a year earlier, and net debt-to-EBITDA improved to 2.4x from 2.6x. However, gross debt rose by USD0.69bn from March 2026 as the company used short-term debt lines to fund seasonal working capital. Net working capital increased to INR159.41bn from INR81.19bn at March 2026 and INR110.25bn a year earlier; inventory, receivables and payables all increased. Non-recourse receivables factoring was INR67.55bn at 30 June 2026, up from INR59.40bn a year earlier.

Management identifies lower early-quarter sales volumes, planned inventory build for Q2, delayed seasonality and foreign-exchange translation as drivers. That explanation is plausible for a global agricultural-inputs business, and the company says around 60% of working capital is funded by long-term sources. Still, the Q1 statements report operating cash flow of negative INR62.04bn and FCFF of negative INR77.78bn, versus negative INR26.87bn and negative INR31.41bn a year earlier. For bondholders, the near-term question is therefore whether inventory and receivables convert during the season without renewed pressure on credit losses, factoring, bank lines or refinancing.

The presentation's maturity graphic identifies scheduled debt repayments of USD500m in FY2027, USD500m in FY2028, USD400m in FY2029 and USD449m in FY2031 across sustainability-linked loan bonds and term loans. It does not replace a full maturity ladder or disclose the relevant contractual protections. The materials reviewed do not establish whether those selected amounts reconcile to total group gross debt or capture every maturity, including any FY2030 obligation; it is therefore useful only as an initial refinancing indicator. The Q1 result also includes INR0.55bn of other income from a long-disputed insurance claim after a Bombay High Court decision; the amount was received before approval of the statements. This cash receipt is favourable at the margin, but it is non-recurring and should not be used to judge recurring cash conversion.

The Q1 results also preserve the distinction between the consolidated UPL Limited group and UPL Corp creditors. UPL Corp's earnings trend is encouraging, but the public materials reviewed for this flash do not provide UPL Corp issuer-level financial statements, the bond guarantee and covenant package, undrawn committed liquidity, or a complete maturity ladder. Improved consolidated margins and a group-level leverage ratio should not be treated as evidence of equivalent repayment capacity or protection for a particular UPL Corp instrument.

4. Reorganisation and What To Watch Next

The proposed Composite Scheme has progressed: the company reports Competition Commission of India approval on 2 June 2026 and exchange observation letters on 29 July 2026. It remains subject to shareholder, regulatory and NCLT approvals, and the Q1 financial statements give it no accounting effect. The planned amalgamation and demerger therefore remain a structural monitoring issue rather than an accomplished change in creditor perimeter or cash-flow allocation.

UPL has guided for FY2027 revenue growth of 7%-11% and EBITDA growth of 10%-14%. This is management guidance, not a verified outcome. The next review should focus on whether the Q2 seasonal conversion reduces working-capital days and short-term debt utilisation, whether UPL Corp volumes recover after the European weather effects, and whether the group sustains margin expansion without greater dependence on price or FX. It should also obtain the Q1 call transcript, independent rating-agency commentary, detailed liquidity and refinancing information, and UPL Corp bond documentation before drawing a security-specific conclusion.

The company presentation also describes CARE Edge's upgrade of UPL Limited's long-term rating to CARE AA+ with a Stable outlook. Because this flash has not independently retrieved the CARE action, it is not incorporated as rating evidence or as a substitute for an assessment of UPL Corp debt. The appropriate next step is to obtain the agency's own release and determine the rated entity, instrument scope, support assumptions and any distinction between domestic UPL Limited facilities and UPL Corp's foreign-currency obligations.

5. Sources